Your browser doesn't support javascript.
loading
Survival following allogeneic transplant in patients with myelofibrosis.
Gowin, Krisstina; Ballen, Karen; Ahn, Kwang Woo; Hu, Zhen-Huan; Ali, Haris; Arcasoy, Murat O; Devlin, Rebecca; Coakley, Maria; Gerds, Aaron T; Green, Michael; Gupta, Vikas; Hobbs, Gabriela; Jain, Tania; Kandarpa, Malathi; Komrokji, Rami; Kuykendall, Andrew T; Luber, Kierstin; Masarova, Lucia; Michaelis, Laura C; Patches, Sarah; Pariser, Ashley C; Rampal, Raajit; Stein, Brady; Talpaz, Moshe; Verstovsek, Srdan; Wadleigh, Martha; Agrawal, Vaibhav; Aljurf, Mahmoud; Angel Diaz, Miguel; Avalos, Belinda R; Bacher, Ulrike; Bashey, Asad; Beitinjaneh, Amer M; Cerny, Jan; Chhabra, Saurabh; Copelan, Edward; Cutler, Corey S; DeFilipp, Zachariah; Gadalla, Shahinaz M; Ganguly, Siddhartha; Grunwald, Michael R; Hashmi, Shahrukh K; Kharfan-Dabaja, Mohamed A; Kindwall-Keller, Tamila; Kröger, Nicolaus; Lazarus, Hillard M; Liesveld, Jane L; Litzow, Mark R; Marks, David I; Nathan, Sunita.
Afiliação
  • Gowin K; Division of Hematology and Oncology, University of Arizona, Tucson, AZ.
  • Ballen K; Division of Hematology and Oncology, University of Virginia Health System, Charlottesville, VA.
  • Ahn KW; Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
  • Hu ZH; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI.
  • Ali H; Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
  • Arcasoy MO; City of Hope, Duarte, CA.
  • Devlin R; Division of Hematology, Department of Medicine, Duke University School of Medicine, Durham, NC.
  • Coakley M; University Health Network, Toronto, ON, Canada.
  • Gerds AT; Institute of Cancer Research, Chelsea, London, United Kingdom.
  • Green M; Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
  • Gupta V; Division of Hematology, Department of Medicine, Duke University School of Medicine, Durham, NC.
  • Hobbs G; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
  • Jain T; Massachusetts General Hospital, Boston, MA.
  • Kandarpa M; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Komrokji R; Department of Internal Medicine, University of Michigan, Ann Arbor, MI.
  • Kuykendall AT; Moffitt Cancer Center, Tampa, FL.
  • Luber K; Moffitt Cancer Center, Tampa, FL.
  • Masarova L; Department of Osteopathic Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO.
  • Michaelis LC; MD Anderson Cancer Center, Houston, TX.
  • Patches S; Hematology and Medical Oncology, Medical College of Wisconsin, Milwaukee, WI.
  • Pariser AC; Dana-Farber Cancer Institute, Boston, MA.
  • Rampal R; Northwestern Memorial Hospital, Chicago, IL.
  • Stein B; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Talpaz M; Northwestern Memorial Hospital, Chicago, IL.
  • Verstovsek S; MD Anderson Cancer Center, Houston, TX.
  • Wadleigh M; MD Anderson Cancer Center, Houston, TX.
  • Agrawal V; Dana-Farber Cancer Institute, Boston, MA.
  • Aljurf M; Division of Hematology-Oncology, Indiana University School of Medicine, Indianapolis, IN.
  • Angel Diaz M; Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.
  • Avalos BR; Department of Hematology/Oncology, Hospital Infantil Universitario Nino Jesus, Madrid, Spain.
  • Bacher U; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Carolinas HealthCare System, Charlotte, NC.
  • Bashey A; Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Beitinjaneh AM; Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA.
  • Cerny J; Department of Medicine, University of Miami, Miami, FL.
  • Chhabra S; Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical Center, Worcester, MA.
  • Copelan E; Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
  • Cutler CS; Levine Cancer Institute, Atrium Health, Carolinas HealthCare System, Charlotte, NC.
  • DeFilipp Z; Department of Medical Oncology, Division of Transplantation and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA.
  • Gadalla SM; Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA.
  • Ganguly S; Division of Cancer Epidemiology & Genetics, Clinical Genetics Branch, National Cancer Institute, National Institutes of Health, Rockville, MD.
  • Grunwald MR; Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City, KS.
  • Hashmi SK; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Carolinas HealthCare System, Charlotte, NC.
  • Kharfan-Dabaja MA; Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.
  • Kindwall-Keller T; Department of Internal Medicine, Mayo Clinic, MN.
  • Kröger N; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL.
  • Lazarus HM; Division of Hematology and Oncology, University of Virginia Health System, Charlottesville, VA.
  • Liesveld JL; Department of Stem Cell Transplantation, University Hospital Hamburg, Hamburg, Germany.
  • Litzow MR; Department of Medicine, Case Western Reserve University, Cleveland, OH.
  • Marks DI; Department of Medicine, University of Rochester Medical Center, Rochester, NY.
  • Nathan S; Division of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester, MN.
Blood Adv ; 4(9): 1965-1973, 2020 05 12.
Article em En | MEDLINE | ID: mdl-32384540

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mielofibrose Primária Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mielofibrose Primária Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article